References
- 1. Otto CM, Prendergast B. Aortic-Valve Stenosis - From Patients at Risk to Severe Valve Obstruction [Internet]. https://doi.org/10.1056/NEJMra1313875. Massachusetts Medical Society; 2014 [cited 2022 Jul 24]. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMra1313875
- 2. Khanji MY, Ricci F, Galusko V, Sekar B, Chahal CAA, Ceriello L, et al. Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations. Eur Heart J - Qual Care Clin Outcomes. 2021 Oct 1;7(4):34053.10.1093/ehjqcco/qcab016829469233751049
- 3. Osnabrugge RLJ, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013 Sep 10;62(11):100212.10.1016/j.jacc.2013.05.01523727214
- 4. Brecker S, Mealing S, Padhiar A, Eaton J, Sculpher M, Busca R, et al. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost- utility analysis based on patient-level data from the ADVANCE study. Open Heart. 2014 Oct 1;1(1):e000155.10.1136/openhrt-2014-000155420793825349700
- 5. Wald DS, Williams S, Bangash F, Bestwick JP. Watchful Waiting in Aortic Stenosis: The Problem of Acute Decompensation. Am J Med. 2018 Feb 1;131(2):1737.10.1016/j.amjmed.2017.08.02728916422
- 6. Monin JL, Lancellotti P, Monchi M, Lim P, Weiss E, Piérard L, et al. Risk Score for Predicting Outcome in Patients With Asymptomatic Aortic Stenosis. Circulation. 2009 Jul 7;120(1):6975.10.1161/CIRCULATIONAHA.108.80885719546391
- 7. Kalavrouziotis D, Li D, Buth KJ, Légaré JF. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study. J Cardiothorac Surg. 2009 Jul 14;4:32.10.1186/1749-8090-4-32271706319602289
- 8. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus Surgical Aortic- Valve Replacement in High-Risk Patients. N Engl J Med. 2011 Jun 9;364(23):218798.10.1056/NEJMoa110351021639811
- 9. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1695705.10.1056/NEJMoa181405230883058
- 10. Swift SL, Puehler T, Misso K, Lang SH, Forbes C, Kleijnen J, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta- analysis. BMJ Open. 2021 Dec 6;11(12):e054222.10.1136/bmjopen-2021-054222865046834873012
- 11. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561632.10.1093/ejcts/ezac20935352803
- 12. The UK TAVI Trial Investigators. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial. JAMA. 2022 May 17;327(19):187587.
- 13. Onorati F, D’Errigo P, Barbanti M, Rosato S, Covello RD, Maraschini A, et al. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. J Thorac Cardiovasc Surg. 2014 May;147(5):152939.10.1016/j.jtcvs.2013.05.03923856202
- 14. D’Ascenzo F, Gonella A, Moretti C, Omedè P, Salizzoni S, La Torre M, et al. Gender differences in patients undergoing TAVI: a multicentre study. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2013 Jul;9(3):36772.10.4244/EIJV9I3A5923872650
- 15. Mangieri A, Montalto C, Pagnesi M, Lanzillo G, Demir O, Testa L, et al. TAVI and Post Procedural Cardiac Conduction Abnormalities. Front Cardiovasc Med [Internet]. 2018 [cited 2022 Mar 22];5. Available from: https://www.frontiersin.org/article/10.3389/fcvm.2018.0008510.3389/fcvm.2018.00085603872930018969
- 16. Cracana I, Vasilcu TF, Mardare A, Alexa ID, Marcu DTM. SEVERE AMIODARONE-INDUCED BRADICARDIA CONCEALES SICK SINUS SYNDROME: CASE REPORT. Med-Surg J. 2016 Mar 31;120(1):1103.
- 17. Marcu DTM, Arsenescu-Georgescu C. Adverse Drug Reactions and Atrioventricular Conduction Disorders-A Female Gender Related Aproach. Intern Med. 2021;18(5):1529.10.2478/inmed-2021-0179
- 18. Lawrie GM. Role of Transcatheter Aortic Valve Implantation (TAVI) Versus Conventional Aortic Valve Replacement in the Treatment of Aortic Valve Disease. Methodist DeBakey Cardiovasc J. 2012;8(2):48.10.14797/mdcj-8-2-4340580622891120
- 19. Clayton B, Morgan-Hughes G, Roobottom C. Transcatheter aortic valve insertion (TAVI): a review. Br J Radiol. 2014 Jan;87(1033):20130595.10.1259/bjr.20130595389897824258463
- 20. Kan T, Gu L, Lu H, Cao J, Zhu Z, Wu D, et al. Improved Transcatheter aortic valve implantation for aortic regurgitation using a new-type stent: the first preclinical experience. J Cardiothorac Surg. 2020 Sep 29;15(1):276.10.1186/s13019-020-01327-4752593432993717
- 21. Guyton RA. The Placement of Aortic Transcatheter Valve (PARTNER) trial: the surgeon’s perspective: celebration and concern. Circulation. 2012 Jun 1;125(25):32379.10.1161/CIRCULATIONAHA.112.09309622733339
- 22. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010 Oct 21;363(17):1597607.10.1056/NEJMoa100823220961243
- 23. Rougé A, Huttin O, Aslam R, Vaugrenard T, Jouve T, Angioi M, et al. Mid-term results of 150 TAVI comparing apical versus femoral approaches. J Cardiothorac Surg. 2015 Nov 3;10:147.10.1186/s13019-015-0360-4463283726530142
- 24. Guinot PG, Depoix JP, Tini L, Vahanian A, Desmonts JM, Montravers P, et al. [Transcutaneous aortic valve implantation: Anesthetic and perioperative management]. Ann Fr Anesth Reanim. 2011 Oct;30(10):73442.10.1016/j.annfar.2011.05.00421723077
- 25. Barth A, Yücel S, Ince H, Doblhammer G. Impact of transcatheter aortic valve implantation on the risk of mortality in patients with severe aortic valve diseases: a health insurance-based analysis. Open Heart. 2018 Apr 21;5(1):e000756.10.1136/openhrt-2017-000756592257029713484
- 26. Anghel R, Adam CA, Marcu DTM, Mitu O, Roca M, Tinica G, et al. Cardiac Rehabilitation in Peripheral Artery Disease in a Tertiary CenterImpact on Arterial Stiffness and Functional Status after 6 Months. Life. 2022 Apr;12(4):601.10.3390/life12040601902456235455092
- 27. Anghel R, Adam CA, Marcu DTM, Mitu O, Mitu F. Cardiac Rehabilitation in Patients with Peripheral Artery DiseaseA Literature Review in COVID-19 Era. J Clin Med. 2022 Jan;11(2):416.10.3390/jcm11020416877800935054109
- 28. Anghel R, Adam CA, Mitu O, Marcu DTM, Onofrei V, Roca M, et al. Cardiac Rehabilitation and Mortality Risk Reduction in Peripheral Artery Disease at 6-Month Outcome. Diagnostics. 2022 Jun;12(6):1500.10.3390/diagnostics12061500922216635741309
- 29. Anghel R, Adam C, Marcu D, Mitu O, Mitu F. IMPACT OF COMORBIDITIES ON THE LONG-TERM PROGNOSIS OF PATIENTS WITH INTERMITTENT CLAUDICATION. Intern Med Interna. 2021;18(6).10.2478/inmed-2021-0186
- 30. Nilsson K, Buccheri S, Christersson C, Koul S, Nilsson J, Pétursson P, et al. Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study. Eur Heart J - Qual Care Clin Outcomes. 2022 Mar 1;8(2):15060.10.1093/ehjqcco/qcab026888812833831187
- 31. De Backer O, Arnous S, Lønborg J, Brooks M, Biasco L, Jönsson A, et al. Recovery from Anemia in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation Prevalence, Predictors and Clinical Outcome. PLoS ONE. 2014 Dec 1;9(12):e114038.10.1371/journal.pone.0114038425019525437191
- 32. Van Mieghem NM, Schultz CJ, van der Boon RMA, Nuis RJ, Tzikas A, Geleijnse ML, et al. Incidence, timing, and predictors of valve dislodgment during TAVI with the Medtronic Corevalve System. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2012 Apr 1;79(5):72632.10.1002/ccd.2327521805601
- 33. Nuis RJ, Sinning JM, Rodés-Cabau J, Gotzmann M, van Garsse L, Kefer J, et al. Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013 Dec;6(6):62534.10.1161/CIRCINTERVENTIONS.113.000409
- 34. Lv Z, Zhou B, Yang C, Wang H. Preoperative Anemia and Postoperative Mortality in Patients with Aortic Stenosis Treated with Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review and Meta- Analysis. Med Sci Monit Int Med J Exp Clin Res. 2019 Sep 27;25:72517.10.12659/MSM.916185677841331559972
- 35. Gul M, Uyarel H, Akgul O, Uslu N, Yildirim A, Eksik A, et al. Hematologic and clinical parameters after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis. Clin Appl Thromb Off J Int Acad Clin Appl Thromb. 2014 Apr;20(3):30410.10.1177/107602961246276223076777
- 36. Takagi H, Hari Y, Kawai N, Ando T. Meta-Analysis of Impact of Anemia and Hemoglobin Level on Survival After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2019 Jan 15;123(2):30614.10.1016/j.amjcard.2018.09.04230401487
- 37. Abu Khadija H, Gandelman G, Ayyad O, Poles L, Jonas M, Paz O, et al. Trends in Transfemoral Aortic Valve Implantation Related Thrombocytopenia. J Clin Med. 2022 Jan 29;11(3):726.10.3390/jcm11030726883683735160176
- 38. Yelgeç NS, Emre A. Prognostic value of lipid levels in short-term outcome after TAVI. Herz. 2020 Jun;45(4): 3828.10.1007/s00059-019-4826-331209519
- 39. Abu Khadija H, Gandelman G, Ayyad O, Jaber M, Poles L, Jonas M, et al. Differential systemic inflammatory responses after TAVI: The role of self versus balloon expandable devices. PLoS ONE. 2021 Oct 26;16(10):e0258963.10.1371/journal.pone.0258963854764134699535
- 40. Calça R, Teles RC, Branco P, Gaspar A, Brito J, Nolasco T, et al. Impact of Transcatheter Aortic Valve Implantation on Kidney Function. Arq Bras Cardiol. 2019 Dec;113(6):110411.
- 41. Keleş T, Ayhan H, Durmaz T, Sarı C, Aslan AN, Erdoğan KE, et al. Improvement in renal functions with transcatheter aortic valve implantation. J Geriatr Cardiol JGC. 2013 Dec;10(4):31722.
- 42. Witberg G, Steinmetz T, Landes U, Pistiner Hanit R, Green H, Goldman S, et al. Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement. JAMA Netw Open. 2021 Mar 26;4(3): e213296.10.1001/jamanetworkopen.2021.3296799807933769507